血液学之外——嵌合抗原受体(CAR)T 细胞治疗皮肤与结缔组织疾病的最新认识
Beyond Hematology-Current Insights into Chimeric Antigen Receptor (CAR) T-Cell Therapy for Skin and Connective Tissue Disorders.
嵌合抗原受体(CAR)T 细胞疗法是现代免疫治疗的一项重大进展。
69.0分
★★★☆☆
ALL SOURCES
Beyond Hematology-Current Insights into Chimeric Antigen Receptor (CAR) T-Cell Therapy for Skin and Connective Tissue Disorders.
嵌合抗原受体(CAR)T 细胞疗法是现代免疫治疗的一项重大进展。
CAR T-Cell Therapy for Cancer: Latest Updates and Challenges, with a Focus on B-Lymphoid Malignancies and Selected Solid Tumours.
尽管如此,在标准治疗难治的晚期神经母细胞瘤中,抗GD2特异性CAR T细胞实现了60%的长期总生存率和63%的客观缓解率。
共 2 条
MEMBER ACCOUNT
登录成功会直接打开下一页。